Contrasting CareDx (CDNA) & Forrester Research (FORR)
CareDx (NASDAQ: CDNA) and Forrester Research (NASDAQ:FORR) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, risk, profitabiliy and valuation.
This table compares CareDx and Forrester Research’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Forrester Research pays an annual dividend of $0.76 per share and has a dividend yield of 1.9%. CareDx does not pay a dividend. Forrester Research pays out 72.4% of its earnings in the form of a dividend.
Risk and Volatility
CareDx has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500. Comparatively, Forrester Research has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500.
This is a breakdown of current ratings and target prices for CareDx and Forrester Research, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Institutional & Insider Ownership
36.5% of CareDx shares are owned by institutional investors. Comparatively, 54.0% of Forrester Research shares are owned by institutional investors. 5.4% of CareDx shares are owned by insiders. Comparatively, 46.6% of Forrester Research shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Earnings & Valuation
This table compares CareDx and Forrester Research’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|CareDx||$45.65 million||0.52||-$11.23 million||($2.01)||-0.55|
|Forrester Research||$325.89 million||2.15||$39.55 million||$1.05||37.62|
Forrester Research has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Forrester Research, indicating that it is currently the more affordable of the two stocks.
Forrester Research beats CareDx on 11 of the 13 factors compared between the two stocks.
CareDx, Inc. is a molecular diagnostics company. The Company is focused on the discovery, development and commercialization of clinically differentiated diagnostic surveillance solutions for transplant patients. The Company’s commercialized testing solution, the AlloMap heart transplant molecular test (AlloMap), is a gene expression test that helps clinicians monitor and identify heart transplant recipients with stable graft function having a low probability of moderate/severe acute cellular rejection. Its products under development for transplant monitoring include AlloSure, a development-stage transplant surveillance solution, which applies next generation sequencing to detect and quantitate genetic differences between donor-derived cell-free deoxyribonucleic acid (dd-cfDNA) in the blood stream emanating from the donor heart. It offers the AlloMap Score Variability service, which provides complementary information to help personalize long-term care of heart transplant recipients.
About Forrester Research
Forrester Research, Inc. (Forrester) is an independent research, data, and advisory services firm. The Company offers research, data, advisory and related services that are thematic, prescriptive and executable, and that provide a perspective on the changing business environment. Its segments include Research, Product and Project Consulting. The Research segment is responsible for writing the research and performing the Webinars and inquiries for its Research and Connect products. The Product segment includes the product management organization that is responsible for product pricing and packaging and the launch of new products. In addition, this segment includes its Data, Connect and Events organizations. The Project Consulting segment offers project consulting services. Its products and services are categorized into Forrester Research, Forrester Connect, Forrester Data, Forrester Consulting and Forrester Events.
Receive News & Ratings for CareDx Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareDx Inc. and related companies with MarketBeat.com's FREE daily email newsletter.